tobramycin
Shortage resolved
The TGA records this shortage as over. Supply reaching individual pharmacies can still take time after a shortage is resolved, so your pharmacy may not have restocked yet.
5 product records on the Australian Register of Therapeutic Goods, listed in full below. The TGA last updated this information on 3 July 2026. Not medical advice.
The TGA does not publish a reason for a shortage, so Voxsanity cannot show one. Nothing on this page is an explanation of why supply is affected — that information is not in the source and is not inferred here.
This is national information. The TGA records shortages for Australia as a whole. There is no state, territory or pharmacy-level stock information in this data, and Voxsanity cannot tell you whether a particular pharmacy has a medicine in stock. Your pharmacist can.
tobramycin is subsidised on the PBS. The active ingredient is on the current Pharmaceutical Benefits Scheme, so it is a medicine dispensed under subsidy across Australia rather than one supplied through a narrower route. That is a fact about how widely it is used, not a rating of how serious this shortage is — the TGA's own impact rating above is the only severity statement on this page, and this does not change it.
A PBS listing is recorded against the active ingredient, while a shortage is usually reported against particular brands, strengths or pack sizes. So a subsidised alternative brand of the same ingredient may still be available even where a shortage is open. Your pharmacist can tell you what is in stock and can discuss substitutions with your prescriber.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.
Products affected
Pfizer (Australia) TOBRAMYCIN (as sulfate) PF 80 mg/2 mL injection ampoule
Injection, solution · ARTG 10776
- Status
- Shortage resolved The TGA records this shortage as over. Supply reaching individual pharmacies can still take time after a shortage is resolved, so your pharmacy may not have restocked yet.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 14 August 2026 The TGA's dates span 0 days.
- Resolved
- 14 August 2026
- TGA last updated
- 3 July 2026
TOBRAMYCIN WKT tobramycin 300mg/5mL solution for inhalation ampoules
Inhalation, conventional · ARTG 279353
- Status
- Shortage resolved The TGA records this shortage as over. Supply reaching individual pharmacies can still take time after a shortage is resolved, so your pharmacy may not have restocked yet.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Critical impact The TGA has assessed this shortage as critical impact. That is a judgement about how hard the medicine is to substitute in clinical care, not a prediction about any one person. If you take this medicine, speak to your pharmacist or doctor about what is available. Do not stop or change how you take it on your own.
- Reported from
- 3 June 2026 The TGA's dates span 22 days.
- Resolved
- 25 June 2026
- TGA last updated
- 28 May 2026
TOBRAMYCIN SUN tobramycin 300 mg/5 mL solution for inhalation ampoule
Inhalation, conventional · ARTG 285709
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 1 May 2026
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 1 August 2025
What the TGA says is being done
Alternative generic products are available.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
DBL TOBRAMYCIN tobramycin 80mg/2mL injection BP vial
Injection, solution · ARTG 75686
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 1 April 2026
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 25 July 2025
What the TGA says is being done
An alternative generic product is available.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
TOBI tobramycin 300mg/5mL solution for inhalation ampoule
Inhalation, conventional · ARTG 73172
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Reduction in supply until supply is exhausted The supplier reports reduced stock, which will run out and not be replaced.
- TGA impact rating
- Medium impact The TGA has assessed this shortage as medium impact, meaning some people may need to change brand, strength or product while it lasts.
- Reported from
- 14 February 2026
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 22 August 2025
What the TGA says is being done
An alternative brand is available.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
Where this comes from
Source: Medicine Shortage Reports Database, Therapeutic Goods Administration (TGA), © Commonwealth of Australia, reproduced with permission. The TGA does not endorse Voxsanity, and nothing here is presented as a TGA view. Shortage information is free for everyone on this site, with no account and no subscription.
To read the TGA's own entry for tobramycin, open the TGA Medicine Shortage Reports Database and type tobramycin into its filter box. The TGA's register has no direct link to an individual medicine, so this is the closest link that exists. General information about medicine shortages is on the TGA's medicine shortages page.
Voxsanity last read the register on 18 August 2026.
Not medical advice. Voxsanity republishes public government health data in plain English. Speak to your pharmacist or doctor about your own medicines. Do not stop or change how you take a medicine because of anything on this page.